MTD vs RANI · P/E 27, rev $3.87B vs rev $1.0M
Mettler-Toledo International Inc (MTD) versus Rani Therapeutics Holdings Inc (RANI) — a side-by-side from cached financials, not a winner call.
Mettler-Toledo International Inc (MTD) is a diagnostics & research company listed on NYSE.
Rani Therapeutics Holdings Inc (RANI) is a biotechnology company listed on US.
Latest reported MTD revenue for 2024-12-31 was $3.87B. Net income was $863.1M. Revenue was up 2.2% from 2023-12-31 to 2024-12-31. MTD currently screens at market cap $23.20B and trailing P/E 26.9.
Latest reported RANI revenue for 2024-12-31 was $1.0M. Net income was -$56.6M. RANI currently screens at market cap $41.5M.
MTD currently screens at market cap $23.20B and trailing P/E 26.9. RANI currently screens at market cap $41.5M.
Not investment advice. Open the MTD and RANI stock pages for the full models.
Not investment advice.